I rather take Pfizer_老虎社区_美港股上老虎

2021-03-25

I rather take Pfizer

AstraZeneca issues updated Phase 3 trial data for its Covid vaccine after facing criticism

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":358011274,"tweetId":"358011274","gmtCreate":1616639622598,"gmtModify":1634524783699,"author":{"id":3573775111920367,"idStr":"3573775111920367","authorId":3573775111920367,"authorIdStr":"3573775111920367","name":"Tiongwee","avatar":"https://static.tigerbbs.com/e90910e406e67c77f42e225b16b69020","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":27,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>I rather take Pfizer</p></body></html>","htmlText":"<html><head></head><body><p>I rather take Pfizer</p></body></html>","text":"I rather take Pfizer","highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/358011274","repostId":1132104091,"repostType":4,"repost":{"id":"1132104091","kind":"news","pubTimestamp":1616635297,"share":"https://www.laohu8.com/m/news/1132104091?lang=&edition=full","pubTime":"2021-03-25 09:21","market":"us","language":"en","title":"AstraZeneca issues updated Phase 3 trial data for its Covid vaccine after facing criticism","url":"https://stock-news.laohu8.com/highlight/detail?id=1132104091","media":"cnbc","summary":"AstraZenecaissued updated Phase 3 trial data for its Covid-19 vaccine on Wednesday after facing crit","content":"<div>\n<p>AstraZenecaissued updated Phase 3 trial data for its Covid-19 vaccine on Wednesday after facing criticism earlier this week over a preliminary report.\nThe companynow says its vaccine is 76% ...</p>\n\n<a href=\"https://www.cnbc.com/2021/03/24/covid-vaccine-astrazeneca-issues-updated-phase-3-trial-data.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AstraZeneca issues updated Phase 3 trial data for its Covid vaccine after facing criticism</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAstraZeneca issues updated Phase 3 trial data for its Covid vaccine after facing criticism\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-25 09:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/03/24/covid-vaccine-astrazeneca-issues-updated-phase-3-trial-data.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>AstraZenecaissued updated Phase 3 trial data for its Covid-19 vaccine on Wednesday after facing criticism earlier this week over a preliminary report.\nThe companynow says its vaccine is 76% ...</p>\n\n<a href=\"https://www.cnbc.com/2021/03/24/covid-vaccine-astrazeneca-issues-updated-phase-3-trial-data.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/6e474d690ea02c536f0fd4c03fc3ddef","relate_stocks":{"AZN":"阿斯利康"},"source_url":"https://www.cnbc.com/2021/03/24/covid-vaccine-astrazeneca-issues-updated-phase-3-trial-data.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1132104091","content_text":"AstraZenecaissued updated Phase 3 trial data for its Covid-19 vaccine on Wednesday after facing criticism earlier this week over a preliminary report.\nThe companynow says its vaccine is 76% effectivein protecting against symptomatic cases of virus. A release issued on Monday reported a symptomatic efficacy rate of 79%. The updated report maintains that the vaccine is 100% effective against severe disease and hospitalization.\nA slate of U.S. health officials criticized the company in recent days for what some saw as data “cherry-picking.”\nThe updated results include data collected from 190 symptomatic cases, an increase of roughly 50 cases studied compared with thedata set released on Monday.\nThe findings suggest the vaccine is more effective in patients aged 65 and older than previously understood, with a newly reported efficacy rate of 85% for that population, up from a previously stated 80%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":366,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["PFE"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":17,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/358011274"}